Last update Aug. 30, 2021
Very Low Risk
Fraction of purified protein isolated from a filtered culture medium of a human strain of Mycobacterium tuberculosis.
Indicated as a test for the diagnosis of tuberculosis.
Plasma absorption from the dermis is nil, so it is very unlikely that a significant amount will pass into breast milk.
Due to its protein nature, it is inactivated in the gastrointestinal tract, not being absorbed (practically nil oral bioavailability), which hinders or prevents the passage into plasma of the infant from ingested breast milk.
It is a test for authorized use in newborns and infants.
The data available on a possible sensitization of infants to tuberculin through breast milk is contradictory and insufficient (Keller 1987, Masters 1982).
Expert authors consider the use of this medication safe during breastfeeding (Hale, LactMed, Lawrence 2016 p424, Schaeffer 2015 p818, Loto 2012).
WHO Essential Medicines List: compatible with breastfeeding (WHO 2002)
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM